Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA (pregabalin) in Primary Generalized Tonic-Clonic Seizures
NEW YORK--(BUSINESS WIRE)--May 24, 2019-- |!| Ludington
NEW YORK--(BUSINESS WIRE)--May 24, 2019-- |!| Ludington